Brielle Benyon

Watch to Dr. Naveen Pemmaraju, from The University of Texas MD Anderson Cancer Center, discuss frontline treatment options for patients with myelofibrosis during the CURE® Educated Patient® MPN Summit.

In honor of CURE®’s 20th anniversary, here is a roundup of some of the major advancements in the world of cancer care, according to experts, patients and advocates.

From eye removal to radiation damage, patients with uveal melanoma may face complications after treatment, although continued and new therapies may address these issues, an expert said.

Research efforts will improve the lives of patients with myelofibrosis, though those advancements may take years to come, an expert said.

Patients with chronic lymphocytic leukemia tended to switch to another regimen or intensify their Calquence treatment quicker than those given Imbruvica, study results showed.

Krazati was granted an accelerated approval for patients with KRAS G12C-mutant locally advanced or metastatic non-small cell lung cancer, according to the Food and Drug Administration.

CURE® took a look at the most popular and practice-changing breast cancer news from 2022. Here’s what we found.

Lifileucel, a personalized adoptive tumor-infiltrating lymphocyte therapy, showed promising responses in patients with pretreated melanoma, according to cohort findings from a recent clinical trial.

From the death of a Broadway actor to TV stars completing treatment, here’s what’s happening in the cancer space this week.

Although researchers analyzed internet searches of men with prostate cancer, patient-provider communication is still key for education, according to one of the study authors.

A recently launched clinical trial of NTX1088 will determine if the novel drug can help overcome immune checkpoint inhibition resistance in patients with locally advanced or metastatic solid tumors.

From Toby Keith providing fans with an update since his stomach cancer diagnosis to Katie Couric donating $25,000 worth of baby formula to moms with breast cancer, here’s what’s happening in the cancer space this week.

Rezlidhia was approved for patients with acute myeloid leukemia based on study results showing that more than one-third of patients experienced a complete remission after taking the drug.

Patient-reported quality of life was better for patients with resected melanoma who received Keytruda compared to interferon or Yervoy, study results showed.

An expert offers three steps that patients can take to become more comfortable and confident with their ostomy after undergoing surgery for gastric cancer.

From a uterine cancer survivor camping out in front of a store to meet the Astros’ Jose Altuve to Michael Armand Hammer’s death from cancer, here’s what’s happening in the cancer space this week.

Watch Dr. Neelima Vidula, from Massachusetts General Hospital, discuss the management of triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

Watch Dr. Arielle J. Medford, from Dana-Farber Cancer Institute, discuss the management of HER2-positive disease during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

The Food and Drug Administration granted a priority review to epcoritamab for certain patients with large B-cell lymphoma, an aggressive type of blood cancer.

Childhood cancer survivors who had high daily sugar intake — especially when it came to sweetened beverages — had an increased risk of premature aging-related health complications, according to recent research.

The recent FDA approval of Libtayo for advanced non-small cell lung cancer added yet another option for the treatment of patients with the disease.

From “Star Trek” actors supporting the Pancreatic Cancer Action Network to Michelle Obama meeting with a sarcoma survivor and an update on Jane Fonda’s cancer, here’s what’s happening in the cancer space this week.

Zolbetuximab plus the chemotherapy regimen mFOLFOX6 improved progression-free survival and overall survival in certain patients with unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.

Tecvayli, which was recently approved for pretreated relapsed/refractory myeloma, is a “much more convenient” treatment option than CAR-T cell therapy, one expert said.

The first patient was enrolled in a phase 1 trial analyzing MTX110 in patients with recurrent glioblastoma, an aggressive type of brain cancer.

While most patients want to learn more about complementary therapies, like exercise and nutrition, before undergoing cancer treatment, barriers exist to both patients and clinicians, research found.

When patients are aware of cancer disparities, it can empower them to be proactive about their care to close the prognostic gap between races.

From odor to diet concerns, a nurse practitioner answers common questions about colostomies and ileostomies from patients with cancer.

The FDA approved Elahere for patients with pretreated, folate receptor alpha (FRα)-positive platinum-resistant gynecological cancers

Patients with myelofibrosis should be open about their treatment goals with their providers, and potentially consider getting a second opinion or participating in a clinical trial, one expert says.